Assessment of virulence diversity of methicillin-resistant Staphylococcus aureus strains with a Drosophila melanogaster infection model

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Wu, Kaiyu ^a   Conly, John ^a,b   Surette, Michael ^a,c   Sibley, Christopher ^a   Elsayed, Sameer ^a,d   Zhang, Kunyan ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Drosophila melanogaster; Infection model; Methicillin resistant Staphylococcus aureus; Virulence

Indexed keywords

ALPHA HEMOLYSIN; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CAENORHABDITIS ELEGANS; COMMUNITY; CONTROLLED STUDY; DIPTERA; DROSOPHILA MELANOGASTER; HOSPITAL; HOST PATHOGEN INTERACTION; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIAL DIVERSITY; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; GENE EXPRESSION; GENETIC VARIATION; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; SURVIVAL ANALYSIS; VIRULENCE; VIRULENCE FACTORS;

ANIMALIA; BACTERIA (MICROORGANISMS); CAENORHABDITIS ELEGANS; DROSOPHILA MELANOGASTER; INVERTEBRATA; MAMMALIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84869864414     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-274     Document Type: Article

References (38)

1. Crossley KB, Jefferson KK, Archer GL, Fowler VG Jr, The staphylococci in human disease West Sussex, UK: Wiley-Blackwell 2 2009
2. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, et al. JAMA 2007 298 15 1763 1771 10.1001/jama.298.15.1763 17940231
3. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ, Kreiswirth BN, et al. J Immunol 2005 175 6 3907 3919 16148137
4. Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain AN, Clasen J, Daum RS, J Infect Dis 2008 198 4 561 570 10.1086/590157 18598194
5. Waves of resistance: Staphylococcus aureus in the antibiotic era. Chambers HF, Deleo FR, Nat Rev Microbiol 2009 7 9 629 641 10.1038/nrmicro2200 19680247
6. Caenorhabditis elegans as a host model for community-associated methicillin-resistant Staphylococcus aureus. Wu K, Conly J, McClure JA, Elsayed S, Louie T, Zhang K, Clin Microbiol Infect 2010 16 3 245 254 10.1111/j.1469-0691.2009.02765.x 19456837
7. Conly J, Wu K, Zhang K, Shurgold J, Gravel D, Campbell J, Mulvey M, Simor A, Byrce E, Loeb M, et al. Comparison of Hospital vs Community Associated Methicillin-Resistant Staphylococcus aureus Strains (MRSA) in the Canadian Nosocomial Infection Surveillance Program from 1995-2005: Correlation of Clinical Invasiveness with a Caenorhabditus elegans Host Model [Abstract] The 14th International Symposium on Staphylococci and Staphylococcal Infection: 2010. (Bath, United Kingdom), 159: abstract 148.
8. The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections. Ferrandon D, Imler JL, Hetru C, Hoffmann JA, Nat Rev Immunol 2007 7 11 862 874 10.1038/nri2194 17948019
9. Drosophila as a model host for Pseudomonas aeruginosa infection. D'Argenio DA, Gallagher LA, Berg CA, Manoil C, J Bacteriol 2001 183 4 1466 1471 10.1128/JB.183.4.1466-1471.2001 11157963
10. Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. Sibley CD, Duan K, Fischer C, Parkins MD, Storey DG, Rabin HR, Surette MG, PLoS Pathog 2008 4 10 1000184 10.1371/journal.ppat.1000184 18949036
11. Drosophila melanogaster is a genetically tractable model host for Mycobacterium marinum. Dionne MS, Ghori N, Schneider DS, Infect Immun 2003 71 6 3540 3550 10.1128/IAI.71.6.3540-3550.2003 12761139
12. Exploration of host-pathogen interactions using Listeria monocytogenes and Drosophila melanogaster. Mansfield BE, Dionne MS, Schneider DS, Freitag NE, Cell Microbiol 2003 5 12 901 911 10.1046/j.1462-5822.2003.00329.x 14641175
13. Secreted bacterial effectors and host-produced Eiger/TNF drive death in a Salmonella-infected fruit fly. Brandt SM, Dionne MS, Khush RS, Pham LN, Vigdal TJ, Schneider DS, PLoS Biol 2004 2 12 418 10.1371/journal.pbio.0020418 15562316
14. Drosophila melanogaster as a model host for Staphylococcus aureus infection. Needham AJ, Kibart M, Crossley H, Ingham PW, Foster SJ, Microbiology 2004 150 Pt 7 2347 2355 15256576
15. Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus. Christianson S, Golding GR, Campbell J, Mulvey MR, J Clin Microbiol 2007 45 6 1904 1911 10.1128/JCM.02500-06 17428941
16. QscR, a modulator of quorum-sensing signal synthesis and virulence in Pseudomonas aeruginosa. Chugani SA, Whiteley M, Lee KM, D'Argenio D, Manoil C, Greenberg EP, Proc Natl Acad Sci U S A 2001 98 5 2752 2757 10.1073/pnas. 051624298 11226312
17. Insect immunity. Septic injury of Drosophila induces the synthesis of a potent antifungal peptide with sequence homology to plant antifungal peptides. Fehlbaum P, Bulet P, Michaut L, Lagueux M, Broekaert WF, Hetru C, Hoffmann JA, J Biol Chem 1994 269 52 33159 33163 7806546
18. Drosophila immunity: methods for monitoring the activity of Toll and Imd signaling pathways. Romeo Y, Lemaitre B, Methods Mol Biol 2008 415 379 394 18370166
19. The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. Kenny JG, Ward D, Josefsson E, Jonsson IM, Hinds J, Rees HH, Lindsay JA, Tarkowski A, Horsburgh MJ, PLoS One 2009 4 2 4344 10.1371/journal.pone.0004344 19183815
20. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 4 402 408 10.1006/meth.2001.1262 11846609
21. The C-terminal region of the S component of staphylococcal leukocidin is essential for the biological activity of the toxin. Nariya H, Izaki K, Kamio Y, FEBS Lett 1993 329 1-2 219 222 8354399
22. Expression of gamma-hemolysin regulated by sae in Staphylococcus aureus strain Smith 5R. Yamazaki K, Kato F, Kamio Y, Kaneko J, FEMS Microbiol Lett 2006 259 2 174 180 10.1111/j.1574-6968.2006.00236.x 16734776
23. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP, Mol Gen Genet 1986 202 1 58 61 10.1007/BF00330517 3007938
24. Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Irazoqui JE, Urbach JM, Ausubel FM, Nat Rev Immunol 2010 10 1 47 58 10.1038/nri2689 20029447
25. The Drosophila melanogaster toll pathway participates in resistance to infection by the gram-negative human pathogen Pseudomonas aeruginosa. Lau GW, Goumnerov BC, Walendziewicz CL, Hewitson J, Xiao W, Mahajan-Miklos S, Tompkins RG, Perkins LA, Rahme LG, Infect Immun 2003 71 7 4059 4066 10.1128/IAI.71.7. 4059-4066.2003 12819096
26. Signaling mechanisms in the antimicrobial host defense of Drosophila. Imler JL, Hoffmann JA, Curr Opin Microbiol 2000 3 1 16 22 10.1016/S1369-5274(99) 00045-4 10679426
27. Differential activation of the NF-kappaB-like factors Relish and Dif in Drosophila melanogaster by fungi and Gram-positive bacteria. Hedengren-Olcott M, Olcott MC, Mooney DT, Ekengren S, Geller BL, Taylor BJ, J Biol Chem 2004 279 20 21121 21127 10.1074/jbc.M313856200 14985331
28. Profiling early infection responses: Pseudomonas aeruginosa eludes host defenses by suppressing antimicrobial peptide gene expression. Apidianakis Y, Mindrinos MN, Xiao W, Lau GW, Baldini RL, Davis RW, Rahme LG, Proc Natl Acad Sci U S A 2005 102 7 2573 2578 10.1073/pnas.0409588102 15695583
29. Virulence gene expression in human community-acquired Staphylococcus aureus infection. Loughman JA, Fritz SA, Storch GA, Hunstad DA, J Infect Dis 2009 199 3 294 301 10.1086/595982 19115951
30. Maximal transcription of aur (aureolysin) and sspA (serine protease) in Staphylococcus aureus requires staphylococcal accessory regulator R (sarR) activity. Gustafsson E, Oscarsson J, FEMS Microbiol Lett 2008 284 2 158 164 10.1111/j.1574-6968.2008.01198.x 18576947
31. The hyaluronate lyase of Staphylococcus aureus-a virulence factor? Makris G, Wright JD, Ingham E, Holland KT, Microbiology 2004 150 Pt 6 2005 2013 15184586
32. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O, Nat Med 2007 13 12 1405 1406 10.1038/nm1207-1405 18064027
33. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, Karin M, Nizet V, Eckmann L, Proc Natl Acad Sci U S A 2009 106 31 12873 12878 10.1073/pnas.0904958106 19541630
34. Vaccine assembly from surface proteins of Staphylococcus aureus. Stranger-Jones YK, Bae T, Schneewind O, Proc Natl Acad Sci U S A 2006 103 45 16942 16947 10.1073/pnas.0606863103 17075065
35. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR, J Infect Dis 2008 198 8 1166 1170 10.1086/592053 18729780
36. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O, DeLeo FR, J Infect Dis 2010 202 7 1050 1058 10.1086/656043 20726702
37. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A, Infect Immun 1993 61 9 3879 3885 8359909
38. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M, Bayer AS, J Clin Invest 1994 94 5 1815 1822 10.1172/JCI117530 7962526